
- DAWN
- PARTNERS
- …
- DAWN
- PARTNERS
- DAWN
- PARTNERS
- …
- DAWN
- PARTNERS

Dawn is a first-in-class digital theragnostic platform.
Delivering customised, targeted curricula, Dawn measures and solves real world mental health issues through validated touchless monitoring neurobehavioral interventions:
- Clinically validated patient programmes
- Market tested performance training
- Inspired wellness experiences
The you, You love.

Personalised
Dawn is personalised for every individual. Because more than anything else, the brain is what makes each of us unique.

Measurements
Dawn’s training is measured, promoting higher engagement and better outcomes through objective and benchmarked quantification of wellbeing. Scalable, easy to use, no wearable required.

Global
Dawn is available world-wide in nine languages (and counting). Administering indication-specific and client-specific content and features, from cancer survivorship and concussion to employee performance, anxiety and rehabilitation.
Dawn DTx has CE MDR Class I, DCB0129, and ISO 27001:2022 certification. It is Software as a Medical Devide (SaMD) with the highest level of data security and clinical risk management.




Certifications
Mobio Interactive’s digital therapeutic platform “Dawn DTx” has CE MDR Class 1, DCB 0129 ,and ISO 27001-2022 certification; and is GDPR-, HIPAA- and PHIPA-compliant.
Validating the accuracy of our digital biomarkers and the efficacy of our digital theragnostic platform, Dawn DTx, Mobio has published over 20 peer-reviewed papers to date from over a dozen completed clinical studies.
Mobio is committed to publishing as much clinical research and technology development in the peer-reveiwed literature as feasible, simultaneously protecting our freedom to operate and tradesecrets.
Effective and accessible healthcare for every human.











